课题基金 / 基金详情

Development Research Project (DRP)

Development Research Project (DRP)
发展研究项目(DRP)
批准号:
10206028
负责人:
David McDermott
金额:
$28.41万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
未结题
起止时间:
2003-09-18 至 2025-08-31

项目摘要

项目成果

David McDermott的其他基金

相似基金

相关文献

中文摘要
翻译
发展项目计划(DRP) 为了确保DF/HCC肾癌孢子中高质量科学努力的持续更新, 并资助将补充或提高DF/HCC肾癌的整体质量的努力 孢子。一般来说,DRP资助了既定的调查人员。根据我们的审查,我们将铭记 包括更多的初级调查员该计划将依赖于 行政、评价和规划核心(行政核心): 1.征集申请和/或确定新的肾癌研究项目。 2.评估这些项目的资金。 3.资助创新发展项目。 4.重新评估项目,以便可能过渡到全面项目状态。 5.评估该计划的成功。
英文摘要
Summary of Developmental Projects Program (DRP) To ensure a continual renewal of high-quality scientific endeavors in the DF/HCC Kidney Cancer SPORE and to fund efforts that will complement or enhance the overall quality of the DF/HCC Kidney Cancer SPORE. In general, the DRP has funded established investigators. Based on our review, we will be mindful of including more junior investigators. This Program will rely on the infrastructure created by the Administrative, Evaluation, and Planning Core (Admin Core) to: 1. Solicit applications and/or identify novel kidney cancer research projects. 2. Evaluate these projects for funding. 3. Fund innovative developmental projects. 4. Re-evaluate projects for possible transition into full project status. 5. Evaluate the success of the program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma
Development Research Project (DRP)
DF/HCC Kidney Cancer SPORE
国内基金
海外基金
Complement C6蛋白抑制DNA损伤修复增敏甲状腺乳头状癌放射性碘治疗的作用及其机制
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    刘宇佳
  • 依托单位: